-- Industry veteran brings more than 30 years of operational experience, in large pharma and emerging stage biotech, private and public companies, with extensive commercial experience and an established track record of financing in the capital markets-- Lerodalcibep, a novel, next generation PCSK9 inhibitor and the...
Related Keywords
University Of Cincinnati , Ohio , United States , Evan Stein , August Troendle , David Cory , Smith Kline , Upjohn Company , Liberate Program , University Of Maryland , Biovail , Prestwick Pharmaceuticals , Therapeutics Inc , College Of Pharmacy , Chief Executive Officer , Chief Operating Officer , Chief Scientific , Eiger Biopharmaceuticals , Senior Vice President , Glaxo Smith Kline ,
vimarsana.com © 2020. All Rights Reserved.